AAPA Members, login to view FREE Full Text for all articles. Not a member? Join today!

Institutional members access full text with Ovid®

Share this article on:

Juvenile idiopathic arthritis: Can you recognize this complex diagnosis?

Isennock, Melissa MPAS, PA-C; Grosel, John M. MD

Journal of the American Academy of Physician Assistants: January 2011 - Volume 24 - Issue 1 - p 22–27

The variable manifestations of JIA make diagnosing it a considerable challenge for clinicians, but early, individualized treatment can decrease the long-term sequelae of the disease.

Melissa Isennock was a student in the Marietta College Pa program when this article was written. John Grosel is an assistant professor in the Marietta Pa program and a staff radiologist for Marietta Imaging, Inc, Marietta, Ohio. The authors have indicated no relationships to disclose relating to the content of this article.


Adalimumab (Humira)

Anakinra (Kineret)

Celecoxib (Celebrex)

Etanercept (Enbrel)

Infliximab (Remicade)

Leflunomide (Arava, generics)

Methotrexate (Rheumatrex, Trexall, generics)

Sulfasalazine (Azulfidine, Azulfidine EN-tabs, generics)

Triamcinolone hexacetonide injection (Aristospan)

© 2011 American Academy of Physician Assistants.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website